AmbAgon Therapeutics
San Francisco
About AmbAgon Therapeutics
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $153.0M
- Last round: Series Unknown (Feb 2025)
- Website: ambagontx.com
- Phone: 650-231-5131
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/ambagon-therapeutics-52338 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.